CN101028450A - Medicinal composition for treating cardica cerebrovascular diseases - Google Patents
Medicinal composition for treating cardica cerebrovascular diseases Download PDFInfo
- Publication number
- CN101028450A CN101028450A CNA2007100553211A CN200710055321A CN101028450A CN 101028450 A CN101028450 A CN 101028450A CN A2007100553211 A CNA2007100553211 A CN A2007100553211A CN 200710055321 A CN200710055321 A CN 200710055321A CN 101028450 A CN101028450 A CN 101028450A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- herba
- people
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 20
- 230000002526 effect on cardiovascular system Effects 0.000 claims abstract description 16
- 208000024172 Cardiovascular disease Diseases 0.000 claims abstract description 15
- 241000207929 Scutellaria Species 0.000 claims abstract description 6
- 239000006187 pill Substances 0.000 claims abstract description 3
- 241000628997 Flos Species 0.000 claims description 8
- 241000237903 Hirudo Species 0.000 claims description 8
- 241000283956 Manis Species 0.000 claims description 8
- 241000237636 Pheretima Species 0.000 claims description 8
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- 241000131808 Scolopendra Species 0.000 claims description 8
- 241000522620 Scorpio Species 0.000 claims description 8
- 239000008194 pharmaceutical composition Substances 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 7
- 241000545442 Radix Species 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 239000009490 scorpio Substances 0.000 claims description 3
- 240000001972 Gardenia jasminoides Species 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 14
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 241000305492 Gastrodia Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 23
- 210000004369 blood Anatomy 0.000 description 23
- 230000001737 promoting effect Effects 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 208000010125 myocardial infarction Diseases 0.000 description 5
- 206010008132 Cerebral thrombosis Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 241000157835 Gardenia Species 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 206010008118 cerebral infarction Diseases 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010039424 Salivary hypersecretion Diseases 0.000 description 2
- 208000008630 Sialorrhea Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 241000213006 Angelica dahurica Species 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- OSKIPPQETUTOMW-YHLOVPAPSA-N N-[(2R,3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-Acetamido-5-[(2R,3S,4S,5R,6R)-4-[(2R,3S,4S,5S,6R)-3-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5R,6R)-6-[[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,5-dihydroxy-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,5-dihydroxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound O[C@@H]1[C@@H](NC(=O)C)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O[C@@H]2[C@H]([C@@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@@H]3[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO[C@@H]3[C@H]([C@@H](O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O[C@@H]4[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)O3)O)O2)O)[C@@H](CO)O1 OSKIPPQETUTOMW-YHLOVPAPSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 239000008203 oral pharmaceutical composition Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of honeyed pills for treating cardiovascular and cerebrovascular diseases is prepared from 23 Chinese-medicinal materials including gastrodia tuber, capejasmine fruit, scutellaria root, corpion, etc.
Description
Technical field:
The present invention relates to a kind of medicine for the treatment of cardiovascular and cerebrovascular disease, especially relating to a kind of is the pharmaceutical composition of the treatment cardiovascular and cerebrovascular disease of feedstock production with the Chinese herbal medicine.
Background technology:
Cardiovascular and cerebrovascular disease generally comprises diseases such as cerebral thrombosis, hypertension, hyperlipidemia, cerebral arteriosclerosis, myocardial infarction, cerebral ischemia, premature beat, and this class disease is a kind of common multiple disease, seriously influences patient's physical and mental health and daily life.
The real cause of disease of cardiovascular and cerebrovascular disease is three fat (cholesterol, triglyceride, the phospholipid) content overproof in the blood, and disequilibrium makes the blood sticking silk fabric that becomes, and the formation blood fat group that is sticked together mutually, the flow velocity of blood is slowed down, and oxygen supply is untimely, thereby causes cardiovascular and cerebrovascular disease.So, as long as adjusting three fat and balance three fat are only the basic of treatment cardiovascular and cerebrovascular disease.
At present, the treatment cardiovascular and cerebrovascular disease is based on Western medicine, and the medicine narrow range of suiting the medicine to the illness, and needs to obey multiple Western medicine sometimes, can not Comprehensive Treatment, furthermore the side effect of Western medicine is also very big.Such as: depressor can only temporarily play hypotensive effect, and blood pressure can rise again after the drug withdrawal; Heart disease is by temporary transient symptomatic treatment such as heart tonifying, coronary artery dilator, only plays mitigation.
Summary of the invention:
Technical problem to be solved by this invention aims to provide the pharmaceutical composition of the treatment cardiovascular and cerebrovascular disease that a kind of curative effect is fast, effect is lasting, have no side effect.
The present invention according to the traditional Chinese medical science to pathogenetic understanding of cardiovascular and cerebrovascular disease and Therapeutic Principle, with reference to the modern pharmacological research achievement, and clinical practice for many years, from motherland's medical treasure-house, filter out following raw material of Chinese medicine medicine, by traditional Chinese medical science prescription theory, make pharmaceutical composition.
Pharmaceutical composition of the present invention is made by following raw materials in weight portion medicine:
Rhizoma Gastrodiae 80-120 Ramulus Uncariae Cum Uncis 20-60 Herba Taxilli 30-70 Fructus Gardeniae 25-80
Radix Scutellariae 20-60 Cortex Eucommiae 40-80 Radix Achyranthis Bidentatae 75-120 Caulis Polygoni Multiflori 40-80
Poria cum Radix Pini 60-100 Herba Leonuri 30-75 Concha Haliotidis 80-120 Scorpio 20-70
Hirudo 50-100 Pheretima 60-100 Flos Carthami 30-60 Rhizoma Chuanxiong 80-130
Radix Angelicae Sinensis 25-80 Radix Salviae Miltiorrhizae 70-120 Radix Astragali 60-120 Scolopendra 50-90
Rhizoma Coptidis 30-80 Cortex Phellodendri 20-75 Squama Manis 30-75
The raw material of Chinese medicine of said ratio is made oral pharmaceutical composition.
Optimum weight part proportioning of pharmaceutical composition of the present invention is:
Rhizoma Gastrodiae 100 Ramulus Uncariae Cum Uncis 40 Herba Taxillis 50 Fructus Gardeniaes 50 Radix Scutellariaes 40
The Cortex Eucommiae 60 Radix Achyranthis Bidentataes 100 Caulis Polygoni Multiflori 60 Poria cum Radix Pinis 80 Herba Leonuris 50
Concha Haliotidis 100 Scorpios 50 Hirudos 80 Pheretimas 80 Flos Carthamis 560
Rhizoma Chuanxiong 100 Radix Angelicae Sinensis 50 Radix Salviae Miltiorrhizaes 100 Radixs Astragali 1020 Scolopendras 70
Rhizoma Coptidis 50 Cortex Phellodendris 50 Squama Maniss 50
The raw material of Chinese medicine of said ratio is made the combination of oral medication of honeyed pill dosage form.
The inventor is by consulting amount of literature data and through clinical practice for many years, determine that " fill blood, purify the blood, promoting blood circulation, by arthralgia due to stagnation of blood, blood circulation promoting and blood stasis dispelling, eliminating evil collateral dredging " is the principles of formulating prescriptions, and then regulate three fat, and blood fat group is faded away, smooth flexible up to blood vessel wall.
Rhizoma Gastrodiae endogenous wind stopping relieving convulsion, suppressing the hyperactive liver and subsiding YANG, wind-damp dispelling, stopping numbness pain in the prescription of the present invention; Ramulus Uncariae Cum Uncis endogenous wind stopping relieving convulsion, heat clearing away suppressing the hyperactive liver; Herba Taxilli wind-damp dispelling, invigorating the liver and kidney, bone and muscle strengthening; Fructus Gardeniae pathogenic fire purging relieving restlessness, clearing away heat-damp and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body; Radix Scutellariae heat clearing and damp drying, eliminating fire and detoxication, hemostasis; Cortex Eucommiae invigorating the liver and kidney, bone and muscle strengthening; Radix Achyranthis Bidentatae blood circulation promoting and blood stasis dispelling, invigorating the liver and kidney, bone and muscle strengthening, inducing diuresis for treating stranguria syndrome, conducting blood to flow downwards; Caulis Polygoni Multiflori tranquilizing by nourishing the heart, collateral dredging dispel the wind; Poria cum Radix Pini exorcises evil spirits that gas, spasmolytic are throbbed with fear, happy key, peace soul, support spirit, tonify deficiency is weary; Herba Leonuri blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema; Concha Haliotidis suppressing the hyperactive liver and subsiding YANG, liver heat removing and eyesight improving; Scorpio endogenous wind stopping relieving convulsion, detoxicating and resolving stagnation of pathogens, removing obstruction in the collateral to relieve pain; The Hirudo removing blood stasis; The Pheretima clearing heat for calming endogenous wind, relieving asthma, collateral dredging, diuresis; The Flos Carthami blood circulation promoting and blood stasis dispelling; Rhizoma Chuanxiong blood-activating and qi-promoting, wind-expelling pain-stopping; Chinese angelica blood supplementing, invigorate blood circulation, pain relieving, intestine moistening; Radix Salviae Miltiorrhizae blood circulation promoting and blood stasis dispelling, removing heat from blood eliminating carbuncle, nourishing blood to tranquillize the mind; Radix Astragali tonifying Qi and lifting yang, benefit are defended consolidating superficial resistance, promoting pus discharge and tissue regeneration strengthening, diuretic detumescent; Scolopendra endogenous wind stopping relieving convulsion, detoxicating and resolving stagnation of pathogens, removing obstruction in the collateral to relieve pain; Rhizoma Coptidis heat clearing and damp drying, eliminating fire and detoxication; Cortex Phellodendri heat clearing and damp drying, eliminating fire and detoxication, reducing the asthenic fever; Squama Manis promoting blood circulation to restore menstrual flow, detumescence and apocenosis.Above-mentioned 23 flavor medicines are worked in coordination, the effect of collaborative playing " fill blood, purify the blood, promoting blood circulation, by arthralgia due to stagnation of blood, blood circulation promoting and blood stasis dispelling, eliminating evil collateral dredging ", thereby regulate three fat, balance three fat meet the traditional Chinese medical science to pathogenetic understanding of cardiovascular and cerebrovascular disease and Therapeutic Principle.
The present invention is made by pure Chinese medicine, no side effects, and preparation technology is simple, stable curative effect, effective percentage reaches 93%.
For showing therapeutic effect of the present invention, the inventor is as follows to the clinical treatment situation statistics of 100 routine various cardiovascular and cerebrovascular diseases.
1. physical data
Hyperpietic 17 people, man 1 people more than 60 years old, woman 5 people more than 60 years old, male 40-60 year 6 people, women 40-60 year 5 people;
Cerebral thrombus patient 20 people, man 3 people more than 60 years old, woman 5 people more than 60 years old, male 40-60 year 8 people, women 40-60 year 4 people;
Cardiac 14 people, man 3 people more than 60 years old, woman 2 people more than 60 years old, male 40-60 year 5 people, women 40-60 year 4 people;
Hyperlipemic patients 16 people, man 5 people more than 60 years old, woman 6 people more than 60 years old, male 40-60 year 2 people, women 40-60 year 3 people;
Cerebral Infarction Patients 15 people, man 8 people more than 60 years old, male 40-60 year 3 people, women 40-60 year 4 people;
Myocardial infarction patient 18 people, man 6 people more than 60 years old, woman 5 people more than 60 years old, male 40-60 year 3 people, women 40-60 year 4 people.
2. Therapeutic Method
Seriously ill person every day three times, each 3 balls, sick the lighter every day twice, each 2 balls, every ball 15 grams, serve on three courses of treatment at 30 days course of treatment.
3. efficacy assessment standard
Produce effects: clinical symptom disappearance, functional rehabilitation is normal, cures and does not have recurrence after 1 year.
Take a turn for the better: clinical symptom relief, stable disease.
Invalid: symptom does not have obvious improvement.
4. therapeutic outcome sees the following form
| Disease | Case load | Produce effects | Take a turn for the better | Invalid | Effective percentage |
| Hypertension | 17 | 11 | 5 | 1 | 94％ |
| Cerebral thrombosis | 20 | 15 | 4 | 1 | 95％ |
| Heart disease | 14 | 9 | 4 | 1 | 93％ |
| Hyperlipidemia | 16 | 14 | 1 | 1 | 94％ |
| Cerebral infarction | 15 | 9 | 5 | 1 | 93％ |
| Myocardial infarction | 18 | 14 | 3 | 1 | 94％ |
From above data show, the present invention treats various cardiovascular and cerebrovascular diseases all better curative effect, and effective percentage reaches 93%.
Model case:
1, Hu Zhendong, man, 48 years old, suffered from cerebral thrombosis, myocardial infarction 6 years, facial hemiparalysis, sialorrhea, walking needs the people to assist in, after taking the present invention (melting the bolt ball) 3 courses of treatment, effect has had tangible improvement, taken 2 courses of treatment again after, do not choose on foot and held up, the symptom of facial hemiparalysis obviously alleviates, also sialorrhea not, and sequela has all disappeared.
2, Lee protects, the man, and 45 years old, suffered from cerebral infarction, hypertension, hyperlipidemia 5 years, language has obstacle when being in a bad way, and the right side body is inactive, goes to toilet on foot and all must someone help, and melts the bolt ball after 1 month by taking, and life just can have been taken care of oneself fully.
3, Liu Guang, the man 55 years old, got myocardial infarction in 2004, after doing support operation and leaving hospital, the state of an illness has had improvement, but feels sensation of oppression over the chest with shortness of breath, takes to melt the bolt ball and just feel that breast is not vexed 2 courses of treatment, also easily how whole body, used a course of treatment at last again, symptom complete obiteration uncomfortable in chest, all very normal so far.
4, Wang Xiu, the woman 56 years old, suffers from myocardial ischemia more than 1 year, like upstairs heart all will be jumped out, weak from head to foot, what is lived is not all done, and takes to melt the bolt ball after 3 courses of treatment, last heart is downstairs jumped to such an extent that do not resembled former severity so, general housework can both have been done, and to examination in hospital, every index is all normal.
5, Li Ayu, the woman 65 years old, suffers from cerebral thrombosis, arrhythmia 5 years, once repeatedly morbidity was in hospital, and numbness of hands and feet be can't take care of oneself, and all are all looked after by my old man, listened relatives to introduce and melted the bolt ball, just used a course of treatment, trick as a result is not numb, continues to have used 2 courses of treatment, state of an illness rehabilitation.
6, Wu is with, man, 49 years old, suffers from a heart complaint, hypertension nervous breathing hard, heart also stops sometimes steathily, has spent a lot of money in the past, does not all cure, and takes to melt two weeks of bolt ball, nervous symptom of breathing hard has just disappeared, and after 2 months, blood pressure is also normal by the time, and heart disease does not commit excesses yet again.
The specific embodiment:
Embodiment 1
Rhizoma Gastrodiae 80 Ramulus Uncariae Cum Uncis 20 Herba Taxillis 30 Fructus Gardeniaes 25 Radix Scutellariaes 20
The Cortex Eucommiae 40 Radix Achyranthis Bidentataes 75 Caulis Polygoni Multiflori 40 Poria cum Radix Pinis 60 Herba Leonuris 30
Concha Haliotidis 80 Scorpios 20 Hirudos 50 Pheretimas 60 Flos Carthamis 30
Rhizoma Chuanxiong 80 Radix Angelicae Sinensis 25 Radix Salviae Miltiorrhizaes 70 Radixs Astragali 60 Scolopendras 50
Rhizoma Coptidis 30 Cortex Phellodendris 20 Squama Maniss 30
Preparation method: take by weighing raw material by prescription, clean, oven dry is ground into 100-150 order fine powder, and fine powder and ripe Mel is even by part by weight blending in 3: 1, and every ball weighs 15 grams.
Embodiment 2
Rhizoma Gastrodiae 100 Ramulus Uncariae Cum Uncis 40 Herba Taxillis 50 Fructus Gardeniaes 50 Radix Scutellariaes 40
The Cortex Eucommiae 60 Radix Achyranthis Bidentataes 100 Caulis Polygoni Multiflori 60 Poria cum Radix Pinis 80 Herba Leonuris 50
Concha Haliotidis 100 Scorpios 50 Hirudos 80 Pheretimas 80 Flos Carthamis 50
Rhizoma Chuanxiong 100 Radix Angelicae Sinensis 50 Radix Salviae Miltiorrhizaes 100 Radixs Astragali 100 Scolopendras 70
Rhizoma Coptidis 50 Cortex Phellodendris 50 Squama Maniss 50
Method for making is with embodiment 1.
Embodiment 3
Rhizoma Gastrodiae 120 Ramulus Uncariae Cum Uncis 60 Herba Taxillis 70 Fructus Gardeniaes 80 Radix Scutellariaes 60
The Cortex Eucommiae 80 Radix Achyranthis Bidentataes 120 Caulis Polygoni Multiflori 80 Poria cum Radix Pinis 100 Herba Leonuris 75
Concha Haliotidis 120 Scorpios 70 Hirudos 100 Pheretimas 100 Flos Carthamis 60
Rhizoma Chuanxiong 130 Radix Angelicae Sinensis 80 Radix Salviae Miltiorrhizaes 120 Radixs Astragali 120 Scolopendras 90
Rhizoma Coptidis 80 Cortex Phellodendris 75 Squama Maniss 75.
Claims (2)
1, a kind of pharmaceutical composition for the treatment of cardiovascular and cerebrovascular disease, it is characterized in that: it is made by following Chinese medicinal raw materials in portion by weight:
Rhizoma Gastrodiae 80-120 Ramulus Uncariae Cum Uncis 20-60 Herba Taxilli 30-70 Fructus Gardeniae 25-80
Radix Scutellariae 20-60 Cortex Eucommiae 40-80 Radix Achyranthis Bidentatae 75-120 Caulis Polygoni Multiflori 40-80
Poria cum Radix Pini 60-100 Herba Leonuri 30-75 Concha Haliotidis 80-120 Scorpio 20-70
Hirudo 50-100 Pheretima 60-100 Flos Carthami 30-60 Rhizoma Chuanxiong 80-130
Radix Angelicae Sinensis 25-80 Radix Salviae Miltiorrhizae 70-120 Radix Astragali 60-120 Scolopendra 50-90
Rhizoma Coptidis 30-80 Cortex Phellodendri 20-75 Squama Manis 30-75.
2, a kind of pharmaceutical composition for the treatment of cardiovascular and cerebrovascular disease according to claim 1, it is characterized in that: it is the honeyed pill of being made by following Chinese medicinal raw materials in portion by weight:
Rhizoma Gastrodiae 100 Ramulus Uncariae Cum Uncis 40 Herba Taxillis 50 Fructus Gardeniaes 50 Radix Scutellariaes 40
The Cortex Eucommiae 60 Radix Achyranthis Bidentataes 100 Caulis Polygoni Multiflori 60 Poria cum Radix Pinis 80 Herba Leonuris 50
Concha Haliotidis 100 Scorpios 50 Hirudos 80 Pheretimas 80 Flos Carthamis 560
Rhizoma Chuanxiong 100 Radix Angelicae Sinensis 50 Radix Salviae Miltiorrhizaes 100 Radixs Astragali 100 Scolopendras 70
Rhizoma Coptidis 50 Cortex Phellodendris 50 Squama Maniss 50.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100553211A CN100540034C (en) | 2007-02-07 | 2007-02-07 | A kind of pharmaceutical composition for the treatment of cardiovascular and cerebrovascular disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2007100553211A CN100540034C (en) | 2007-02-07 | 2007-02-07 | A kind of pharmaceutical composition for the treatment of cardiovascular and cerebrovascular disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101028450A true CN101028450A (en) | 2007-09-05 |
| CN100540034C CN100540034C (en) | 2009-09-16 |
Family
ID=38714107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2007100553211A Expired - Fee Related CN100540034C (en) | 2007-02-07 | 2007-02-07 | A kind of pharmaceutical composition for the treatment of cardiovascular and cerebrovascular disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100540034C (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101658640B (en) * | 2009-08-25 | 2011-04-13 | 路正平 | Drug for treating cervical vertigo |
| CN101485858B (en) * | 2009-02-10 | 2011-09-07 | 孙强 | Application of Chinese herbal medicine hirudo in cerebrovascular disease |
| CN102258702A (en) * | 2011-09-07 | 2011-11-30 | 刘雅娟 | Medicine for treating hypertension |
| CN102824461A (en) * | 2012-09-17 | 2012-12-19 | 郭玲玲 | Medicine for treating hypertension and preparation method thereof |
| CN103110693A (en) * | 2013-02-06 | 2013-05-22 | 长沙理工大学 | Composition for preventing, treating or assisting in treating cardiovascular and cerebrovascular diseases or chronic diseases, and preparation method and application thereof |
| CN103689961A (en) * | 2012-09-27 | 2014-04-02 | 赵成喜 | Mattress for treating hypertension and heart disease |
| CN105617039A (en) * | 2016-03-02 | 2016-06-01 | 罗维芳 | Traditional Chinese medicine composition for treating brain infarction and preparation method thereof |
| CN105727001A (en) * | 2016-04-06 | 2016-07-06 | 李颖博 | Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases |
| CN110193076A (en) * | 2019-07-15 | 2019-09-03 | 吴文喜 | A kind of Chinese medicine composition and preparation for treating hypertension, hyperlipidemia, high blood viscosity |
| CN113750064A (en) * | 2021-09-09 | 2021-12-07 | 牛鸿祥 | A Chinese medicinal pill for treating cardiovascular diseases |
-
2007
- 2007-02-07 CN CNB2007100553211A patent/CN100540034C/en not_active Expired - Fee Related
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101485858B (en) * | 2009-02-10 | 2011-09-07 | 孙强 | Application of Chinese herbal medicine hirudo in cerebrovascular disease |
| CN101658640B (en) * | 2009-08-25 | 2011-04-13 | 路正平 | Drug for treating cervical vertigo |
| CN102258702A (en) * | 2011-09-07 | 2011-11-30 | 刘雅娟 | Medicine for treating hypertension |
| CN102258702B (en) * | 2011-09-07 | 2012-08-29 | 刘雅娟 | Medicine for treating hypertension |
| CN102824461A (en) * | 2012-09-17 | 2012-12-19 | 郭玲玲 | Medicine for treating hypertension and preparation method thereof |
| CN103689961A (en) * | 2012-09-27 | 2014-04-02 | 赵成喜 | Mattress for treating hypertension and heart disease |
| CN103110693A (en) * | 2013-02-06 | 2013-05-22 | 长沙理工大学 | Composition for preventing, treating or assisting in treating cardiovascular and cerebrovascular diseases or chronic diseases, and preparation method and application thereof |
| CN103110693B (en) * | 2013-02-06 | 2015-01-21 | 长沙理工大学 | Composition for preventing, treating or assisting in treating cardiovascular and cerebrovascular diseases or chronic diseases, and preparation method and application thereof |
| CN105617039A (en) * | 2016-03-02 | 2016-06-01 | 罗维芳 | Traditional Chinese medicine composition for treating brain infarction and preparation method thereof |
| CN105727001A (en) * | 2016-04-06 | 2016-07-06 | 李颖博 | Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases |
| CN110193076A (en) * | 2019-07-15 | 2019-09-03 | 吴文喜 | A kind of Chinese medicine composition and preparation for treating hypertension, hyperlipidemia, high blood viscosity |
| CN113750064A (en) * | 2021-09-09 | 2021-12-07 | 牛鸿祥 | A Chinese medicinal pill for treating cardiovascular diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100540034C (en) | 2009-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100540034C (en) | A kind of pharmaceutical composition for the treatment of cardiovascular and cerebrovascular disease | |
| CN101028507A (en) | Chinese-medicinal composition for treating asthma | |
| CN1895620A (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN101708237B (en) | Medicinal composition used for tonifying qi and invigorating pulse, preparation method thereof and application thereof | |
| CN1390585A (en) | Chinese medicine for detoxication purpose and its preparing process | |
| CN103041336B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN100512852C (en) | Composite Chinese medicine took orally for treating coronary heart disease | |
| CN101062263A (en) | Medicine for treating coronary heart disease | |
| CN103721082B (en) | A kind of Chinese medicine composition of cure scapulohumeral periarthritis | |
| CN102940757A (en) | Medicine composition for treating diabetic foot | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN101549057A (en) | Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same | |
| CN101596270A (en) | A kind of medicine that is used for the treatment of chronic pharyngitis and preparation method thereof | |
| CN1162163C (en) | Chinese herbal medicinal liquor for curing rheumatic arthritis | |
| CN103212041A (en) | Chinese medicinal composition treating coronary heart disease | |
| CN108635457A (en) | A kind of Chinese medicine composition and the preparation method and application thereof for treating constipation | |
| CN103585517A (en) | Drug composition for treating hepatitis and cholecystitis and preparation method thereof | |
| CN102397391A (en) | Medicine for treating hypertension, hyperlipemia and blood hyperviscosity and preparation method thereof | |
| CN102600251A (en) | Compound rheumatism-rehabilitating composite agent | |
| CN102225132A (en) | Traditional Chinese medicine compound for treating hyperlipidaemia, cerebral arteriosclerosis and ischemic stroke and preparation method thereof | |
| CN101244209B (en) | Medicament for preventing or treating cardiovascular and cerebrovascular diseases | |
| CN105833152A (en) | Traditional Chinese medicine composition for treating endocrine dyscrasia | |
| CN1296091C (en) | Chinese traditional medicine composition for treating psoriasis | |
| CN1559502A (en) | Chinese medicinal composition for treating sexual dysfunction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090916 Termination date: 20100207 |